Larvol Delta - Nash-Pharmaceuticals-announces-positive-preclinical-results-for-its-lead-compound-NP178-in-a-new-study-for-Crohns-disease

NP-178 - Breathtec Biomedical

NP-120 - Breathtec Biomedical

http://globenewswire.com/news-release/2018/12/03/1660663/0/en/Nash-Pharmaceuticals-Announces-Positive-Pre-Clinical-Results-For-Its-Lead-Compound-NP-178-in-a-New-Study-for-Crohn-s-Disease.html

Dec 3, 2018

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next